Efficacy and safety of cytokines versus first-line sunitinib and second-line axitinib for patients with metastatic renal cell carcinoma (ESCAPE study): A study protocol for phase III randomized sequential open-label study
| Image |  |
|---|---|
| Description | scientific article published on 26 June 2019 |
| Author/s |
author: Naoya Masumori |
| Publication date | June 26, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |